We have placed cookies on your device to improve this website. You can change your cookie settings at any time and receive further information regarding cookies . Otherwise, we will assume you're OK to continue.
You are now leaving Kedrion Corporate site. Medical information including licensed uses may be different outside of the EU countries.
Kedrion Swiss is a biopharmaceutical company specializing in marketing, sales and distribution of plasma derivatives in Switzerland. Kedrion Swiss was founded in 2009 and is based in Zug, Switzerland. We are a wholly-owned subsidiary of Kedrion International GmbH based in Vienna, Austria. In turn, Kedrion International GmbH is a wholly owned subsidiary of Kedrion S.p.A., based in Castelvecchio, Italy. Kedrion Swiss distributes Kedrion products exclusively in Switzerland.
Kedrion Swiss provides plasma derivative therapies for:
- Immune system diseases and
- Illnesses and conditions that require critical care.
Human Normal Immunoglobulins
Human Albumin Solutions
Uman Albumin (Human Albumin / Albumina Humana / Kedrialb)
These high-safety therapies are produced by Kedrion S.p.A. from human plasma collected only in Europe and the USA.